To test whether VEGF-A controls sVEGFR1-i13 in tumor cell lines, we treated MGH7 and H2170 squamous lung carcinoma cells for 24 hours with various recombinant splice variants of VEGF-A, namely rhVEGF121, rhVEGF165 and rhVEGF189. This evidence concerns the gene VEGFA and neoplasm.